BR9914792A - Uso de agentes antifúngicos para tratamento deescleroses - Google Patents
Uso de agentes antifúngicos para tratamento deesclerosesInfo
- Publication number
- BR9914792A BR9914792A BR9914792-0A BR9914792A BR9914792A BR 9914792 A BR9914792 A BR 9914792A BR 9914792 A BR9914792 A BR 9914792A BR 9914792 A BR9914792 A BR 9914792A
- Authority
- BR
- Brazil
- Prior art keywords
- antifungal agents
- sclerosis
- fungi
- derived
- genus
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
Patente de Invenção para "USO DE AGENTES ANTIFúNGICOSPARA TRATAMENTO DE ESCLEROSES". A invenção se refereao uso de agentes antifúngicos ativos sobre os fungos do gêneroCândida, e como no caso podendo ser do gênero Rodhotorula,para preparação medicinais para prevenção ou tratamento dasescleroses dos tecidos, e outras patologias derivadas, noshumanos ou nos animal, relacionados à presença no organismohumano ou animal dos fungos derivados a partir daquelesmencionados acima.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/FR1998/002302 WO2000024402A1 (fr) | 1998-10-27 | 1998-10-27 | Utilisation d'antifongiques dans le traitement des scleroses |
PCT/FR1999/002617 WO2000024403A1 (fr) | 1998-10-27 | 1999-10-27 | Utilisation d'antifongiques dans le traitement des scleroses |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9914792A true BR9914792A (pt) | 2001-11-27 |
Family
ID=9523370
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9914792-0A BR9914792A (pt) | 1998-10-27 | 1999-10-27 | Uso de agentes antifúngicos para tratamento deescleroses |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1124560A1 (pt) |
JP (1) | JP2002528064A (pt) |
CN (1) | CN1328466A (pt) |
AU (2) | AU1036999A (pt) |
BR (1) | BR9914792A (pt) |
CA (1) | CA2348160A1 (pt) |
IL (1) | IL142641A0 (pt) |
WO (2) | WO2000024402A1 (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9915625D0 (en) * | 1999-07-02 | 1999-09-01 | Cortendo Ab | Method |
CN110269939A (zh) * | 2019-03-12 | 2019-09-24 | 武汉愔紫生物科技有限公司 | 一种治疗真菌分泌蛋白介导的炎症疾病标志物的药物、药物组合物、用途及其使用方法 |
CN110343650B (zh) * | 2019-05-28 | 2020-12-29 | 浙江工业大学 | 一种产两性霉素b的重组结节链霉菌及其应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA941298A (en) * | 1969-07-07 | 1974-02-05 | Schmid, (Julius) Inc. | Composition containing polyenic macrolide and aryl derivative of aliphatic acid |
US4289757A (en) * | 1978-02-28 | 1981-09-15 | The Upjohn Company | Method for treating inflammation |
US5358959A (en) * | 1993-02-18 | 1994-10-25 | President And Fellows Of Harvard University | Methods for treating arteriosclerosis |
GB2290707A (en) * | 1994-06-28 | 1996-01-10 | Georgi Stankov | Pharmaceutical uses of Amphotericin B |
GB2290709A (en) * | 1994-06-28 | 1996-01-10 | Georgi Stankov | Pharmaceutical uses of nystatin |
-
1998
- 1998-10-27 AU AU10369/99A patent/AU1036999A/en not_active Abandoned
- 1998-10-27 WO PCT/FR1998/002302 patent/WO2000024402A1/fr unknown
-
1999
- 1999-10-27 AU AU63471/99A patent/AU6347199A/en not_active Abandoned
- 1999-10-27 CA CA002348160A patent/CA2348160A1/fr not_active Abandoned
- 1999-10-27 EP EP99950850A patent/EP1124560A1/fr not_active Withdrawn
- 1999-10-27 CN CN99813799A patent/CN1328466A/zh active Pending
- 1999-10-27 IL IL14264199A patent/IL142641A0/xx unknown
- 1999-10-27 BR BR9914792-0A patent/BR9914792A/pt not_active Application Discontinuation
- 1999-10-27 WO PCT/FR1999/002617 patent/WO2000024403A1/fr not_active Application Discontinuation
- 1999-10-27 JP JP2000578012A patent/JP2002528064A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
IL142641A0 (en) | 2002-03-10 |
CA2348160A1 (fr) | 2000-05-04 |
EP1124560A1 (fr) | 2001-08-22 |
WO2000024403A1 (fr) | 2000-05-04 |
AU6347199A (en) | 2000-05-15 |
JP2002528064A (ja) | 2002-09-03 |
WO2000024402A1 (fr) | 2000-05-04 |
AU1036999A (en) | 2000-05-15 |
CN1328466A (zh) | 2001-12-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0311313A (pt) | Derivados de diaril uréia úteis para o tratamento de doenças dependentes de proteìna cinase | |
BR0109446A (pt) | Medicamento para a aplicação intracorpórea, uso de um xanteno halogenado, composição farmacêutica, e, método de tratamento | |
ATE386533T1 (de) | Kosmetische zubereitungen enthaltend polyhexamethhylenbiguanid-hydrochlorid und distearyldimethylammoniumchlorid | |
BR0013010A (pt) | Formulação de cloreto de sódio de moxifloxacina | |
MX9100042A (es) | Reduccion o prevencion de irritacion de la piel por drogas | |
BR0010531A (pt) | Composições e usos de et743 para tratamento de câncer | |
TR200101649T2 (tr) | Piperazin türevleri. | |
PT1001792E (pt) | Utilizacao de compostos de sais e de complexos de vanadio aceites fisiologicamente | |
CA2216569A1 (fr) | Utilisation de derives d'oxazolidinone comme agents anti-penetrants dans une composition cosmetique et/ou dermatologique | |
BR0200921A (pt) | Uso de produtos de legume para o tratamento de agressões externas | |
BR9814214A (pt) | Composição com ácido azeláico | |
HK1037980A1 (en) | Use of selegiline or desmethylselegiline for the manufacture of a medicament for treating wounds, burns or photodamage. | |
BR9913337A (pt) | Derivados tan-1057 | |
BR9914792A (pt) | Uso de agentes antifúngicos para tratamento deescleroses | |
ATE185274T1 (de) | Therapeutisches mittel gegen drohenden abortus | |
CY1106702T1 (el) | Χρηση ενος συνδυασμου μιας πουρινης και ενος παραγοντα δοτη μονοξειδιου του αζωτου για την προληψη ή την αγωγη γενετησιων δυσλειτουργιων | |
BR0104586A (pt) | Método para tratamento de neurodegeneração | |
ATE238050T1 (de) | 4-cyano-4-deformylsordarizin-derivate | |
ES2190499T3 (es) | Uso de antagonistas de bradiquinina para la preparacion de medicamentos para el tratamiento y la prevencion de la enfermedad de alzheimer. | |
DE69815355D1 (de) | 4-cyano-4-deformylsordarinderivate | |
FR2747572B1 (fr) | Nouvelles compositions cosmetiques, dermopharmaceutiques ou veterinaires pour le traitement aseptisant de la peau humaine ou animale | |
BR0303384A (pt) | Citalopram e seus usos no tratamento de pressão sanguìnea elevada | |
FR2818147B1 (fr) | Nouvelle application therapeutique d'un derive de la thienyclyclohexylamine | |
RU2000124052A (ru) | Способ профилактики и лечения маститов у коров | |
IL110888A0 (en) | Pharmaceutical compositions for the treatment of liver diseases comprising a benzothiazepine derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |